Our Solutions   by Brands   Veil P   Maball-Ra 500

Maball-Ra 500

Maball-Ra 500

*To be consumed as directed by physician.

Therapies:

Rheumatology

Composition:

Rituximab 500 mg/50 ml

About Maball RA 500mg Rituximab Injection for RA & Cancer

Maball-RA 500 Solution for Infusion (50 ml) contains Rituximab 500 mg, a monoclonal antibody that targets CD20-positive B lymphocytes (B cells). It is used in the treatment of Rheumatoid Arthritis (RA), Non-Hodgkin Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Granulomatosis with Polyangiitis (GPA), and Microscopic Polyangiitis (MPA). Rituximab works by selectively destroying abnormal or overactive B cells involved in autoimmune diseases and certain blood cancers, helping reduce inflammation, slow disease progression, and improve treatment outcomes. Maball-RA should only be administered under the supervision of an experienced healthcare professional.

Maball-Ra 500

*To be consumed as directed by physician.


Usage Instructions

  • Maball-RA 500 Solution for Infusion should be administered only by a qualified healthcare professional in a hospital or infusion centre.
  • The dose, infusion schedule, and duration of treatment depend on the condition being treated, body size, and clinical response.
  • Premedication with antihistamines, corticosteroids, or antipyretics may be given before the infusion to reduce the risk of infusion-related reactions.
  • Regular monitoring of blood counts, liver function, kidney function, and Hepatitis B screening is recommended before and during treatment.
  • Do not miss scheduled infusion appointments or discontinue treatment without consulting your specialist.

    • Benefits and Use

  • Maball-RA 500 Solution for Infusion is used to treat Rheumatoid Arthritis, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis.
  • Rituximab selectively targets CD20-positive B cells, helping reduce abnormal immune activity in autoimmune diseases and destroy cancerous B cells in certain blood cancers.
  • This helps reduce inflammation, relieve pain and swelling, slow disease progression, improve immune-mediated conditions, and enhance overall treatment outcomes when used as part of specialist-directed therapy.

    • Safety Information

  • Pregnancy:
  • Rituximab is not recommended during pregnancy unless the potential benefits clearly outweigh the risks. Effective contraception should be used during treatment and for the period advised by your doctor after the last dose.
  • Breastfeeding:
  • Breastfeeding should generally be avoided during treatment and until the medicine has been adequately cleared from the body, as advised by your physician.
  • Infection Risk:
  • Maball-RA can reduce the body's ability to fight infections. Inform your doctor immediately if you develop fever, sore throat, persistent cough, rash, or any signs of infection.
  • Hepatitis B:
  • Patients should undergo Hepatitis B screening before treatment, as Rituximab may reactivate previous Hepatitis B infection.
  • Kidney & Liver Disorders:
  • Use with caution in patients with kidney or liver disease and under close medical supervision.
  • Vaccinations:
  • Inform your doctor if you are planning to receive any vaccinations, as certain vaccines may not be suitable during treatment.
  • Heart Conditions:
  • Tell your doctor if you have heart disease or abnormal heart rhythms before receiving the infusion.
  • Driving:
  • If you experience dizziness, weakness, or infusion-related reactions, avoid driving or operating machinery until you feel well.
  • Inform your doctor about all medicines you are taking before starting treatment.

    • Ingredients

    Rituximab 500 mg

    How to Use

  • Maball-RA 500 Solution for Infusion is administered as a slow intravenous (IV) infusion by a doctor or trained healthcare professional.
  • Do not self-administer.
  • The infusion rate may be adjusted depending on your tolerance and any infusion-related reactions.
  • Follow your doctor's instructions regarding blood tests, vaccinations, and follow-up visits throughout treatment.

    • Storage Information

  • Store refrigerated at 2°C–8°C.
  • Do not freeze.
  • Keep the vial in the original carton to protect it from light.